Dehydroepiandrosterone reduces expression and activity of BACE in NT 2 neurons exposed to oxidative stress

Neurobiology of Disease

Volumn 14, Issue 2, 2003, Pages 291-301

  Tamagno, E ^a   Guglielmotto, M ^a   Bardini, P ^a   Santoro, G ^a   Davit, A ^a   Di Simone, D ^a   Danni, O ^a   Tabaton, M ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Alzheimer's disease; Antioxidants; BACE; DHEA; NT2 neurons; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; ASPARTIC PROTEINASE; BETA SECRETASE; CORTICOSTEROID; MESSENGER RNA; PRASTERONE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SYNTHESIS; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0142219838     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00131-1     Document Type: Article

References (60)

1. Aragno M., Parola S., Brignardello E., Manti R., Betteto S., Tamagno E., Danni O., Boccuzzi G. Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone. Free Radical Biol. Med. 31:2001;935-942.
2. Aragno M., Parola S., Brignardello E., Mauro A., Tamagno E., Manti R., Danni O., Bocuzzi G. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes. 49:2000;1924-1931.
3. Balieu E.E. Steroid hormones in the brain several mechanisms? Fuxe K., Gustafson J.A., Wettenberg L. Steroid Hormone Regulation of the Brain. 1981;3-14 Pergamon, Oxford.
4. Bastianetto S., Ramassamy C., Poirier J., Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res. Mol. Brain Res. 66:1999;35-41.
5. Beekman M., Ungard J.T., Gasior M., Carter R.B., Dijkstra D., Goldberg S.R., Witkin J.M. Reversal of behavioural effects of pentylenetetrazol by the neuroactive steroid ganaxolone. J. Pharmacol. Exp. Ther. 284:1998;868-877.
6. Boccuzzi G., Aragno M., Seccia M., Brignardello E., Tamagno E., Albano E., Danni O., Bellomo G. Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radical Biol. Med. 22:1997;1289-1294.
7. Brignardello E., Gallo M., Aragno M., Manti R., Tamagno E., Danni O., Boccuzzi G. Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells. J. Endocrinol. 166:2000;401-406.
8. Brown R.C., Han Z., Cascio C., Papadopoulos V. Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology. Neurobiol. Aging. 24:2003;57-65.
9. Butterfield D.A., Castegna A., Lauderback C.M., Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging. 23:2002;655-664.
10. Butterfield D.A., Griffin S., Munch G., Pasinetti G.M. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J. Alzheimers Dis. 4:2002;193-201.
11. Cardounel A., Regelson W., Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death mechanisms of action . Proc. Soc. Exp. Biol. Med. 222:1999;145-149.
12. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science. 262:1993;689-695.
13. Edgar D.M., Seidel W.F., Gee K.W., Field G., Xia H., Hawkinson J.E., Wieland S., Carter R.B., Wood P.L. CCD-3693 an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat . J. Pharmacol. Exp. Ther. 282:1997;420-429.
14. ++ in rat liver microsomes. Biochem. J. 208:1982;129-140.
15. Esterbauer H., Koller E., Slee R.G., Koster J.F. Possible involvement of the lipid peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids. Biochem. J. 239:1986;405-409.
16. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biol. Med. 11:1991;81-128.
17. Ferrari E., Casarotti D., Muzzoni B., Alberelli N., Crivello L., Fioravanti M., Bruno S., Solerte B., Magri F. Age-related changes of the adrenal secretory pattern possible role in pathological brain aging . Brain Res. Rev. 37:2001;294-300.
18. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
19. Frederikse P.H., Garland D., Zigler J.S., Piatigorsky J. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (A-beta) in mammalian lens, and A-beta has toxic effects on lens ephitelial cells. J. Biol. Chem. 271:1996;10169-10174.
20. Fukumoto H., Cheung B.S., Hyman B.T., Irizzary M.C. β-Secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59:2002;1381-1389.
21. Gallo M., Aragno M., Gatto V., Tamagno E., Brignardello E., Manti R., Danni O., Boccuzzi G. Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line. Eur. J. Endocrinol. 141:1999;35-39.
22. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E., Zheng H., Van der Ploeg L.H., Ruffolo S.C., Thornberry N.A., Xanthoudakis S., Zamboni T.R.J., Roy S., Nicholson D.W. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic Abeta peptide formation. Cell. 97:1999;395-406.
23. Haas C., Koo E.H., Mellow A., Hung A.Y., Selkoe D.J. Targeting of cell surface β amyloid precursor protein to lysosomes, alternative processing into amyloid-bearing fragments. Nature. 327:1992;500-503.
24. Hamilton N.M. Interaction of steroids with the GABA(A) receptor. Curr. Top. Med. Chem. 2:2002;887-902.
25. Hensley K., Carney J., Mattson M., Aksenova M., Harris M., Wu J., Floyd R., Butterfield D. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide relevance to Alzheimer disease . Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
26. Holsinger R.M.D., McLean C.A., Beyreuther K., Masters C.L., Evin G. Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol. 51:2002;783-786.
27. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Soutan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell Neurosci. 14:1999;419-427.
28. Kawahara M., Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein channel formation and disruption of calcium homeostasis . Brain Res. Bull. 53:2000;389-397.
29. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 95:1998;1852-1857.
30. Klegeris A., McGeer P. β amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 49:1997;229-235.
31. Lin X., Koelsh G., Wu S., Downs D., Dashti A., Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 97:2000;1456-1460.
32. Luchsinger J.A., Tang M.-X., Shea S., Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59:2002;1258-1263.
33. Mao X., Barger S.W. Neuroprotection by dehydroepiandrosterone-sulfate role of an NFkappaB-like factor . NeuroReport. 9:1998;759-763.
34. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated tau. J. Neurochem. 68:1997;255-264.
35. Mattwes D.E., Farewell V.T. Using and Understanding Medical Statistics. second revised:1988;Karger, Basel.
36. Miyamoto H., Marwah P., Marwah A., Lardy H., Chang C. 3β-Acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity. Proc. Natl. Acad. Sci. USA. 100:2003;4440-4444.
37. Mellon S.H. Neurosteroids biochemistry, modes of action and clinical relevance . J. Clin. Endocrinol. Metab. 78:1994;1003-1008.
38. 2 cells. Biochem. Biophys. Res. Commun. 268:2000;642-646.
39. Pratico D., Uryu K., Leight S., Trojanoswski J.Q., Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21:2001;4183-4187.
40. Raber J., Bongers G., LeFevour A., Buttini M., Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. J. Neurosci. 22:2002;5204-5209.
41. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Davignon J., Quirion R., Poirier J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radical Biol. Med. 27:1999;544-553.
42. Roth G.S., Lane M.A., Ingram D.K., Mattison J.A., Elahi D., Tobin J.D., Muller D., Metter E.J. Biomarkers of caloric restriction may predict longevity in humans. Science. 297:2002;811.
43. Russo C., Salis S., Dolcini V., Venezia V., Song X.H., Teller J.K., Schettini G. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Neurobiol. Dis. 8:2001;173-180.
44. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
45. Selkoe D.J. Alzheimer's disease genes, proteins, and therapy . Physiol. Rev. 81:2001;741-766.
46. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavelo R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walzer D., Zhao J., McConlog L., John V. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature. 402:1999;537-540.
47. Takeda A., Smith M.A., Avilà J., Nunomura A., Siedlak S.L., Zhu X., Perry G., Sayre L.M. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75:2000;1234-1241.
48. 2 neurons. Neurobiol. Dis. 10:2002;279-288.
49. MAPK.
50. Teller J.K., Russo C., DeBusk L.M., Angelini G., Zaccheo D., Dagna-Bricarelli F., Scartezzini P., Bertolini S., Mann D.M., Tabaton M., Gambetti P. Presence of solubile amyloid beta-peptide precedes amyloid claque formation in Down's syndrome. Nature Med. 21:1996;93-95.
51. Uzunova V., Sheline Y., Davis J.N., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. USA. 95:1998;3239-3244.
52. Valeè M., Mayo W., Darnaudery M., Corpechot C., Young J., Koehl M., LeMoal M., Balieu E.E., Robel P., Simon H. Neurosteroids deficit cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus . Proc. Natl. Acad. Sci. USA. 94:1997;14856-14870.
53. Vallée M., Mayo W., LeMoal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive ageing. Brain Res. Rev. 37:2001;301-312.
54. Vassar R. β-Secretase (BACE) as a drug target for alzheimer's disease. Adv. Drug Del. Rev. 54:2002;1589-1602.
55. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. β secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741.
56. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashler J.R., Stratman N.C., Mathews W.R., Bulh A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature. 402:1999;533-537.
57. Yanase T., Fukahori M., Taniguchi S., Nishi Y., Sakai Y., Takayanagi R., Haji M., Nawata H. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocr. J. 43:1996;119-123.
58. Yang L.-B., Lindholm R., Yan R., Citron M., Xia W., Yang X.-L., Beach T., Sue L., Wong P., Price D., Li R., Shen Y. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nature Med. 9:2003;3-4.
59. Weill-Engerer S., David J.-P., Sazdovitch V., Liere P., Eychenne B., Pianos A., Schumacher M., Delacourte A., Baulieu E.E., Akwa Y. Neurosteroid quantification in human brain regions comparison between Alzheimer's and nondemented patients . J. Clin. Endocrinol. Metab. 87:2002;5138-5143.
60. Wolkowitz O.M., Kramer J.H., Reus V.I., Costa M.M., Yaffe K., Walton P., Raskind M., Peskind E., Newhouse P., Sack D., De Souza E., Sadowsky C., Roberts E. DHEA treatment of Alzheimer's disease. A randomized, double-blind, placebo-controlled study. Neurology. 60:2003;1071-1076.